46 related articles for article (PubMed ID: 15022409)
1. [New immunological weapons for medicine in the 21st Century: biological therapy based on the use of the latest generation monoclonal antibodies].
Aguillón JC; Contreras J; Dotte A; Cruzat A; Catalán D; Salazar L; Molina MC; Guerrero J; López M; Soto L; Salazar-Onfray F; Cuchacovich M
Rev Med Chil; 2003 Dec; 131(12):1445-53. PubMed ID: 15022409
[TBL] [Abstract][Full Text] [Related]
2. Emerging biologic drugs for the treatment of rheumatoid arthritis.
Puppo F; Murdaca G; Ghio M; Indiveri F
Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092
[TBL] [Abstract][Full Text] [Related]
3. [B cell depletion therapy using anti-CD20 antibodies in rheumatoid arthritis].
Yukawa N; Mimori T
Clin Calcium; 2007 Apr; 17(4):569-76. PubMed ID: 17404487
[TBL] [Abstract][Full Text] [Related]
4. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine modulation induced by selective blockade of TNF-alpha in rheumatoid arthritis.
di Comite G; Marinosci A; Di Matteo P; Manfredi A; Rovere-Querini P; Baldissera E; Aiello P; Corti A; Sabbadini MG
Ann N Y Acad Sci; 2006 Jun; 1069():428-37. PubMed ID: 16855170
[TBL] [Abstract][Full Text] [Related]
6. Veltuzumab, an anti-CD20 mAb for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and immune thrombocytopenic purpura.
Milani C; Castillo J
Curr Opin Mol Ther; 2009 Apr; 11(2):200-7. PubMed ID: 19330725
[TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy.
Shin IS; Baer AN; Kwon HJ; Papadopoulos EJ; Siegel JN
Arthritis Rheum; 2006 May; 54(5):1429-34. PubMed ID: 16645971
[TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.
Jazirehi AR; Bonavida B
Oncogene; 2005 Mar; 24(13):2121-43. PubMed ID: 15789036
[TBL] [Abstract][Full Text] [Related]
9. Infliximab use in luminal Crohn's disease.
Richter JA; Bickston SJ
Gastroenterol Clin North Am; 2006 Dec; 35(4):775-93. PubMed ID: 17129813
[TBL] [Abstract][Full Text] [Related]
10. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.
Bendtzen K; Geborek P; Svenson M; Larsson L; Kapetanovic MC; Saxne T
Arthritis Rheum; 2006 Dec; 54(12):3782-9. PubMed ID: 17133559
[TBL] [Abstract][Full Text] [Related]
11. Antibody guided precision radiation therapy.
Brady ED; Milenic DE; Brechbiel MW
Discov Med; 2004 Jun; 4(22):213-9. PubMed ID: 20704989
[TBL] [Abstract][Full Text] [Related]
12. Emerging Therapies: Spectrum of Applications of Monoclonal Antibody Therapy.
Waldmann TA; Levy R; Coller BS
Hematology Am Soc Hematol Educ Program; 2000; ():394-408. PubMed ID: 11701553
[TBL] [Abstract][Full Text] [Related]
13. Computational engineering the binding affinity of Adalimumab monoclonal antibody for designing potential biosimilar candidate.
Khan MA; Turjya RR; Islam ABMMK
J Mol Graph Model; 2021 Jan; 102():107774. PubMed ID: 33130388
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic monoclonal antibodies.
Breedveld FC
Lancet; 2000 Feb; 355(9205):735-40. PubMed ID: 10703815
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 - April 1, 2016, Tours, France.
Desoubeaux G; Reichert JM; Sleeman M; Reckamp KL; Ryffel B; Adamczewski JP; Sweeney TD; Vanbever R; Diot P; Owen CA; Page C; Lerondel S; Le Pape A; Heuze-Vourc'h N
MAbs; 2016; 8(6):999-1009. PubMed ID: 27266390
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies and therapy of human cancers.
Funaro A; Horenstein AL; Santoro P; Cinti C; Gregorini A; Malavasi F
Biotechnol Adv; 2000 Aug; 18(5):385-401. PubMed ID: 14538101
[TBL] [Abstract][Full Text] [Related]
17. Biological therapy and dentistry: a review paper.
Radfar L; Ahmadabadi RE; Masood F; Scofield RH
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Nov; 120(5):594-601. PubMed ID: 26372436
[TBL] [Abstract][Full Text] [Related]
18. The production of more useful monoclonal antibodies 2. The use of somatic-cell genetic and recombinant-DNA technology to tailor-make monoclonal antibodies.
Agulla HL; Pollock RR; Spira G; Scharff MD
Immunol Today; 1986 Dec; 7(12):380-3. PubMed ID: 25291336
[TBL] [Abstract][Full Text] [Related]
19. Adalimumab in the treatment of immune-mediated diseases.
Lapadula G; Marchesoni A; Armuzzi A; Blandizzi C; Caporali R; Chimenti S; Cimaz R; Cimino L; Gionchetti P; Girolomoni G; Lionetti P; Marcellusi A; Mennini FS; Salvarani C
Int J Immunopathol Pharmacol; 2014; 27(1 Suppl):33-48. PubMed ID: 24774505
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
